1. Home
  2. INGN vs CNTN Comparison

INGN vs CNTN Comparison

Compare INGN & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.27

Market Cap

168.6M

Sector

Health Care

ML Signal

HOLD

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$3.26

Market Cap

184.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INGN
CNTN
Founded
2001
2017
Country
United States
United States
Employees
N/A
3
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
168.6M
184.2M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
INGN
CNTN
Price
$6.27
$3.26
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
224.0K
465.7K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
N/A
EPS
N/A
N/A
Revenue
$348,668,000.00
N/A
Revenue This Year
$7.92
N/A
Revenue Next Year
$7.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$5.34
$3.07
52 Week High
$9.13
$5.27

Technical Indicators

Market Signals
Indicator
INGN
CNTN
Relative Strength Index (RSI) 51.57 33.14
Support Level $6.26 $3.11
Resistance Level $6.83 $3.51
Average True Range (ATR) 0.25 0.29
MACD -0.01 -0.02
Stochastic Oscillator 51.55 15.83

Price Performance

Historical Comparison
INGN
CNTN

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Share on Social Networks: